Therapeutics based on natural killer cells (NKT), a subset of immune cells, intended for the treatment of autoimmune and inflammatory diseases in add...
There’s no risk. Start your trial today to see profiles of NKT Therapeutics plus 5056 other startups.
The Medtech Pro Platform has Expanded! Request Demo
Replay LSI2021 Emerging Medtech Summit Play Now
New 2021 Forecasts Released New Data
New 2021 Forecasts Released Learn More
Become a Medtech Market ProLearn More